Coronavirus illness 2019 (COVID-19) has troubled tens of tens of millions of individuals, fostering and unprecedent effort in vaccine growth and distribution. Healthcare staff (HCW) play a key position in vaccine promotion and affected person steering, and it’s possible that hesitancy amongst this inhabitants may have a significant influence on the adoption of a profitable immunization coverage. To analyze HCW attitudes in direction of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) vaccination, we developed an nameless on-line cross-sectional survey. 1723 Italian HCW responded. Total, 1155 (67%) supposed to be vaccinated, whereas 443 (26%) weren’t positive and 125 (7%) declared refusal. In multivariate evaluation, elements related to hesitancy had been utilizing Fb as the principle data supply and being a non-physician HCW, whereas predictors of acceptance included youthful age, being in shut contact with high-risk teams and having acquired flu vaccination throughout the 2019-2020 season. Causes for hesitancy included lack of belief in vaccine security (85%) and receiving little (78%) or conflicting (69%) details about vaccines. Based on our outcomes, ample funding in vaccine schooling for healthcare personnel seems to be urgently wanted, prioritizing non-physicians and data high quality unfold by way of social media. We hope that our knowledge may assist governments and policy-makers to focus on communication within the ongoing COVID-19 vaccination marketing campaign.
The purpose of this empirical analysis was to offer helpful data for well being system managers on the prices and investments concerned in bettering the standard of the Nationwide Well being Service (NHS) based mostly on affected person assessments and from a gender perspective, i.e., with out assuming that the perceived expertise is an identical for women and men. A cross-sectional research of 31 variables was utilized utilizing partial least squares structural equation modeling (PLS-SEM) as a analysis software. The information had been obtained from the Spanish Ministry of Well being, Consumption, and Social Welfare for your complete Spanish territory between 2005 and 2018. The affect of expenditure, useful resource allocation, and mortality was hypothesized with regard to affected person satisfaction in line with disconfirmation concept. Affected person satisfaction displays scientific effectiveness, and due to this fact is a measure of well being system high quality. The outcomes present that girls are extra delicate to public funding in well being than males, i.e., a rise within the degree of spending and assets will increase satisfaction extra in ladies. In each sexes, the extent of expenditure has a direct affect on affected person satisfaction, and due to this fact on the standard of the healthcare system
Prevalence of nasal carriers of methicillin-resistant Staphylococcus aureus in main well being care models in Brazil
Nasal carriage of Staphylococcus aureus by healthcare staff is of nice scientific significance because it facilitates the contamination of medical gadgets and cross-transmission. Nevertheless, research relating to the epidemiology and dissemination of S. aureus and Methicillin-resistant S. aureus (MRSA) throughout the Main Well being Care in Brazil are scarce. The present research aimed to detect and characterize S. aureus and MRSA strains from the nasal cavities of 63 healthcare working in main well being care models as a way to decide the prevalence of S. aureus and MRSA, biofilm formation and resistance profile of those isolates. PCR reactions had been carried out for detecting mecA, icaA and icaD genes. The phenotypic antimicrobial susceptibility was assessed by the disk diffusion technique and biofilm formation by the Congo Pink Agar (CRA) technique.
The MRSA isolates had been typed for the Staphylococcal Cassette Chromosome mec (SCCmec). The prevalence of nasal carriage of S. aureus was 74.6%, of which 72.3% had been MRSA carrying SCCmec sort I (24.4%), III (34.1%), IV (36.6%). Two (4.9%) isolates offered a non-typeable cassette by the carried out method. The antimicrobial susceptibility analysis evidenced penicillin resistance in 66.1% of S. aureus, erythromycin resistance in 49.2%, whereas 37.3% had been immune to oxacillin, 28.8% to cefoxitin, 5.1% to levofloxacin and 5.1% to clindamycin. All isolates had been biofilm producers and 96.6% of the strains contained the ica biofilm-forming genes (icaA and/or icaD). We’ve demonstrated a excessive prevalence of S. aureus and MRSA carriage amongst well being care working in Main Well being Care models, the presence of SCCmec varieties I, III and IV, along with their excessive capacity to kind biofilm, elements that presumably contribute to the dissemination and persistence of those pathogens throughout the main care companies. These observations spotlight the significance of broadening the attitude of Well being Care-Related Infections prevention, together with all well being care ranges, that are at present little explored. As well as, the dynamics and resistance mechanisms of S. aureus transmission nonetheless should be additional clarified to allow the implementation of simpler prevention measures.
Digital well being literacy intervention to help maternal, youngster and household well being in main healthcare settings of Pakistan throughout the age of coronavirus: research protocol for a randomised managed trial
There’s a must proceed main healthcare companies by way of digital communication for deprived ladies residing in underdeveloped areas of Pakistan, particularly within the age of the coronavirus pandemic, social distancing and lockdown of communities. This undertaking would be the first of its form in aiming to implement a digital well being literacy intervention, utilizing smartphone and web, to deprived ladies by way of feminine neighborhood healthcare staff. Improved well being literacy in ladies of reproductive years is thought to advertise maternal, youngster and household well being general.
 Anti-Integrin beta antibody |
|
STJ93732 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Rabbit polyclonal to Integrin beta1. |
Anti-Integrin beta antibody |
|
STJ93733 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Rabbit polyclonal to Integrin beta1. |
Anti-Integrin beta antibody |
|
STJ93734 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Rabbit polyclonal to Integrin beta2. |
Anti-Integrin beta antibody |
|
STJ93735 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Rabbit polyclonal to Integrin beta3. |
Anti-Integrin beta antibody |
|
STJ93736 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Rabbit polyclonal to Integrin beta3. |
Anti-Integrin beta antibody |
|
STJ93737 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Rabbit polyclonal to Integrin beta4. |
Anti-Integrin beta antibody |
|
STJ93738 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Rabbit polyclonal to Integrin beta5. |
Anti-Integrin beta antibody |
|
STJ99322 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Rabbit polyclonal to Integrin beta7. |
 anti-Integrin beta 1 |
|
YF-PA12789 |
Abfrontier |
100 ug |
EUR 403 |
|
Description: Rabbit polyclonal to Integrin beta 1 |
 anti-Integrin beta 5 |
|
YF-PA12792 |
Abfrontier |
100 ug |
EUR 403 |
|
Description: Rabbit polyclonal to Integrin beta 5 |
 anti-Integrin beta 7 |
|
YF-PA12796 |
Abfrontier |
50 ug |
EUR 363 |
|
Description: Mouse polyclonal to Integrin beta 7 |
anti-Integrin beta 7 |
|
YF-PA12797 |
Abfrontier |
100 ug |
EUR 403 |
|
Description: Rabbit polyclonal to Integrin beta 7 |
 anti-Integrin beta 3 |
|
YF-PA24020 |
Abfrontier |
50 ul |
EUR 334 |
|
Description: Mouse polyclonal to Integrin beta 3 |
 anti-Integrin beta 4 |
|
YF-PA24021 |
Abfrontier |
50 ul |
EUR 334 |
|
Description: Mouse polyclonal to Integrin beta 4 |
anti-Integrin beta 5 |
|
YF-PA24023 |
Abfrontier |
50 ul |
EUR 334 |
|
Description: Mouse polyclonal to Integrin beta 5 |
 Anti-beta 2 Microglobulin/B2m Antibody |
|
A00456-2 |
BosterBio |
100ug/vial |
EUR 294 |
 Integrin beta 2/CD18 |
|
MO15172 |
Neuromics |
500 ug |
EUR 753 |
Integrin beta 2/CD18 |
|
GT15252 |
Neuromics |
100 ug |
EUR 740 |
 Integrin beta 2 antibody |
|
70R-13788 |
Fitzgerald |
100 ug |
EUR 322 |
|
Description: Affinity purified Rabbit polyclonal Integrin beta 2 antibody |
) Anti-Beta 2 Microglobulin Antibody (monoclonal, 2H10) |
|
M00456-2 |
BosterBio |
100ug/vial |
EUR 334 |
 Anti-Integrin beta 3 antibody |
|
STJ99085 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Mouse monoclonal to Integrin beta 3. |
 anti- Integrin beta-1 antibody |
|
FNab04349 |
FN Test |
100µg |
EUR 505.25 |
|
|
|
Description: Antibody raised against Integrin beta-1 |
 anti- Integrin beta-3 antibody |
|
FNab04350 |
FN Test |
100µg |
EUR 505.25 |
|
|
|
Description: Antibody raised against Integrin beta-3 |
 anti- Integrin beta-4 antibody |
|
FNab04351 |
FN Test |
100µg |
EUR 505.25 |
|
|
|
Description: Antibody raised against Integrin beta-4 |
 anti- Integrin beta-5 antibody |
|
FNab04352 |
FN Test |
100µg |
EUR 505.25 |
|
|
|
Description: Antibody raised against Integrin beta-5 |
 anti- Integrin beta-6 antibody |
|
FNab04353 |
FN Test |
100µg |
EUR 505.25 |
|
|
|
Description: Antibody raised against Integrin beta-6 |
 anti- Integrin beta-7 antibody |
|
FNab04355 |
FN Test |
100µg |
EUR 505.25 |
|
|
|
Description: Antibody raised against Integrin beta-7 |
) Anti-Integrin beta 5 (1D8) |
|
YF-MA13874 |
Abfrontier |
100 ug |
EUR 363 |
|
Description: Mouse monoclonal to Integrin beta 5 |
) Anti-Integrin beta 7 (8D3) |
|
YF-MA13876 |
Abfrontier |
100 ug |
EUR 363 |
|
Description: Mouse monoclonal to Integrin beta 7 |
 Protein) Human Integrin Beta 2 (ITGb2) Protein |
|
20-abx067290 |
Abbexa |
-
EUR 662.00
-
EUR 272.00
-
EUR 2040.00
-
EUR 787.00
-
EUR 481.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Human Integrin Beta 2 (ITGb2) Protein |
|
20-abx166642 |
Abbexa |
-
EUR 662.00
-
EUR 272.00
-
EUR 2040.00
-
EUR 787.00
-
EUR 481.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Goat Anti-Integrin beta 2/CD18 Polyclonal Antibody |
|
CTA-523-100ug |
Creative Biolabs |
100ug |
Ask for price |
|
Description: Goat anti-Integrin beta 2/CD18 polyclonal antibodyfor WB, Flow, CyTOF-ready, Func. |
Goat Anti-Integrin beta 2/CD18 Polyclonal Antibody |
|
CTA-523-1mg |
Creative Biolabs |
1mg |
Ask for price |
|
Description: Goat anti-Integrin beta 2/CD18 polyclonal antibodyfor WB, Flow, CyTOF-ready, Func. |
 Rabbit Anti-Integrin beta 2/CD18 Polyclonal Antibody |
|
CTA-525-100ug |
Creative Biolabs |
100ug |
Ask for price |
|
Description: Rabbt anti-Integrin beta 2/CD18 polyclonal antibodyfor WB, IHC, IHC-P. |
Rabbit Anti-Integrin beta 2/CD18 Polyclonal Antibody |
|
CTA-525-1mg |
Creative Biolabs |
1mg |
Ask for price |
|
Description: Rabbt anti-Integrin beta 2/CD18 polyclonal antibodyfor WB, IHC, IHC-P. |
 Rabbit Polyclonal antibody Anti-CRBN |
|
Anti-CRBN |
ImmunoStep |
50 µg |
EUR 349 |
) Recombinant Integrin Beta 2 (ITGb2) |
|
4-RPB586Hu01 |
Cloud-Clone |
-
EUR 476.32
-
EUR 230.00
-
EUR 1511.20
-
EUR 570.40
-
EUR 1040.80
-
EUR 382.00
-
EUR 3628.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Human Integrin Beta 2 expressed in: E.coli |
Recombinant Integrin Beta 2 (ITGb2) |
|
4-RPB586Hu02 |
Cloud-Clone |
-
EUR 476.32
-
EUR 230.00
-
EUR 1511.20
-
EUR 570.40
-
EUR 1040.80
-
EUR 382.00
-
EUR 3628.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Human Integrin Beta 2 expressed in: E.coli |
Recombinant Integrin Beta 2 (ITGb2) |
|
4-RPB586Mu01 |
Cloud-Clone |
-
EUR 494.24
-
EUR 235.00
-
EUR 1578.40
-
EUR 592.80
-
EUR 1085.60
-
EUR 394.00
-
EUR 3796.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Mouse Integrin Beta 2 expressed in: E.coli |
Recombinant Integrin Beta 2 (ITGb2) |
|
4-RPB586Ra01 |
Cloud-Clone |
-
EUR 503.20
-
EUR 238.00
-
EUR 1612.00
-
EUR 604.00
-
EUR 1108.00
-
EUR 400.00
-
EUR 3880.00
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
|
|
Description: Recombinant Rat Integrin Beta 2 expressed in: E.coli |
 Antibody) Integrin Beta 2 (ITGb2) Antibody |
|
20-abx128476 |
Abbexa |
-
EUR 411.00
-
EUR 133.00
-
EUR 1149.00
-
EUR 565.00
-
EUR 314.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Antibody) Integrin Beta 2 (ITGB2) Antibody |
|
abx117239-100ug |
Abbexa |
100 ug |
EUR 467 |
|
|
 Antibody) Integrin Beta-2 (CD18) Antibody |
|
20-abx121570 |
Abbexa |
-
EUR 300.00
-
EUR 439.00
-
EUR 189.00
|
|
|
|
Integrin Beta 2 (ITGB2) Antibody |
|
20-abx323734 |
Abbexa |
|
|
|
|
Integrin Beta 2 (ITGB2) Antibody |
|
20-abx001785 |
Abbexa |
-
EUR 411.00
-
EUR 592.00
-
EUR 182.00
-
EUR 314.00
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
|
Integrin Beta 2 (ITGb2) Antibody |
|
20-abx101485 |
Abbexa |
-
EUR 411.00
-
EUR 133.00
-
EUR 1149.00
-
EUR 565.00
-
EUR 314.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Integrin Beta 2 (ITGb2) Antibody |
|
20-abx101486 |
Abbexa |
-
EUR 425.00
-
EUR 133.00
-
EUR 1177.00
-
EUR 578.00
-
EUR 328.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Integrin Beta 2 (ITGb2) Antibody |
|
20-abx101487 |
Abbexa |
-
EUR 439.00
-
EUR 133.00
-
EUR 1233.00
-
EUR 592.00
-
EUR 328.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
Integrin Beta-2 (CD18) Antibody |
|
20-abx133978 |
Abbexa |
-
EUR 356.00
-
EUR 565.00
-
EUR 300.00
|
|
|
|
Integrin Beta-2 (CD18) Antibody |
|
abx140068-01mg |
Abbexa |
0.1 mg |
EUR 342 |
|
|
Integrin Beta-2 (CD18) Antibody |
|
abx140067-01mg |
Abbexa |
0.1 mg |
EUR 286 |
|
|
Integrin Beta-2 (CD18) Antibody |
|
abx140226-01mg |
Abbexa |
0.1 mg |
EUR 356 |
|
|
Integrin Beta-2 (CD18) Antibody |
|
abx139641-01mg |
Abbexa |
0.1 mg |
EUR 356 |
|
|
Integrin Beta-2 (CD18) Antibody |
|
abx139642-01mg |
Abbexa |
0.1 mg |
EUR 356 |
|
|
Integrin Beta-2 (CD18) Antibody |
|
abx139643-01mg |
Abbexa |
0.1 mg |
EUR 384 |
|
|
Integrin Beta-2 (CD18) Antibody |
|
abx139644-01mg |
Abbexa |
0.1 mg |
EUR 384 |
|
|
Integrin Beta-2 (CD18) Antibody |
|
abx010515-100ul |
Abbexa |
100 ul |
EUR 411 |
|
|
Integrin Beta 2 (ITGB2) Antibody |
|
abx025504-100ul |
Abbexa |
100 ul |
EUR 523 |
|
|
Integrin Beta 2 (ITGB2) Antibody |
|
abx025505-400ul |
Abbexa |
400 ul |
EUR 523 |
|
|
Integrin Beta 2 (ITGB2) Antibody |
|
abx025505-80l |
Abbexa |
80 µl |
EUR 286 |
|
|
Integrin Beta 2 (ITGB2) Antibody |
|
abx030025-400ul |
Abbexa |
400 ul |
EUR 523 |
|
|
Integrin Beta 2 (ITGB2) Antibody |
|
abx030025-80l |
Abbexa |
80 µl |
EUR 286 |
|
|
Integrin Beta 2 (ITGB2) Antibody |
|
abx030031-400ul |
Abbexa |
400 ul |
EUR 523 |
|
|
Integrin Beta 2 (ITGB2) Antibody |
|
abx030031-80l |
Abbexa |
80 µl |
EUR 286 |
|
|
Integrin Beta-2 (CD18) Antibody |
|
abx413358-01mg |
Abbexa |
0.1 mg |
EUR 453 |
|
|
Integrin Beta-2 (CD18) Antibody |
|
abx413682-02mg |
Abbexa |
0.2 mg |
EUR 565 |
|
|
Integrin Beta-2 (CD18) Antibody |
|
abx413686-25ug |
Abbexa |
25 ug |
EUR 272 |
|
|
Integrin Beta-2 (CD18) Antibody |
|
abx413687-1mg |
Abbexa |
1 mg |
EUR 829 |
|
|
Integrin Beta-2 (CD18) Antibody |
|
abx414996-02mg |
Abbexa |
0.2 mg |
EUR 565 |
|
|
Integrin Beta-2 (CD18) Antibody |
|
abx414997-05mg |
Abbexa |
0.5 mg |
EUR 829 |
|
|
Integrin Beta-2 (CD18) Antibody |
|
abx414999-01mg |
Abbexa |
0.1 mg |
EUR 439 |
|
|
Integrin Beta-2 (CD18) Antibody |
|
abx415364-01mg |
Abbexa |
0.1 mg |
EUR 453 |
|
|
Integrin Beta-2 (CD18) Antibody |
|
abx415525-02mg |
Abbexa |
0.2 mg |
EUR 565 |
|
|
Integrin Beta 2 (ITGB2) Antibody |
|
abx430553-200ul |
Abbexa |
200 ul |
EUR 384 |
|
|
Integrin Beta-2 (CD18) Antibody |
|
abx200153-100ug |
Abbexa |
100 ug |
EUR 328 |
|
|
Integrin Beta 2 (ITGB2) Antibody |
|
20-abx213174 |
Abbexa |
|
|
|
|
Integrin Beta 2 (ITGB2) Antibody |
|
20-abx211572 |
Abbexa |
|
|
|
|
 Antibody) Integrin Beta 2 (CD18) Antibody |
|
20-abx172963 |
Abbexa |
|
|
|
|
Integrin Beta 2 (ITGB2) Antibody |
|
20-abx302256 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
Integrin Beta 2 (ITGB2) Antibody |
|
20-abx326380 |
Abbexa |
|
|
|
|
 Anti-Beta Amyloid Antibody |
|
A00081-2 |
BosterBio |
100uL |
EUR 443 |
|
Description: Rabbit Polyclonal Beta Amyloid Antibody. Validated in ELISA, IF, IHC, WB and tested in Human, Mouse. |
 Anti-Integrin beta 3/ITGB3 Antibody |
|
PA1627 |
BosterBio |
100ug/vial |
EUR 334 |
 Anti-Integrin beta 4/ITGB4 Antibody |
|
PA1702 |
BosterBio |
100ug/vial |
EUR 334 |
Anti-Integrin beta 4/ITGB4 Antibody |
|
PA1702-1 |
BosterBio |
100ug/vial |
EUR 294 |
Anti-Integrin beta 4/ITGB4 Antibody |
|
PB9007 |
BosterBio |
100ug/vial |
EUR 334 |
 Anti-Integrin beta 1/ITGB1 Antibody |
|
PB9086 |
BosterBio |
100ug/vial |
EUR 334 |
Anti-Integrin beta 3/ITGB3 Antibody |
|
PB9806 |
BosterBio |
100ug/vial |
EUR 334 |
 antibody) Anti-Phospho-Integrin beta (T758) antibody |
|
STJ91331 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Rabbit polyclonal to Phospho-Integrin beta2 (T758). |
 antibody) Anti-Phospho-Integrin beta (T788) antibody |
|
STJ90303 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Rabbit polyclonal to Phospho-Integrin beta1 (T788). |
 antibody) Anti-Phospho-Integrin beta (Y773) antibody |
|
STJ90304 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Rabbit polyclonal to Phospho-Integrin beta3 (Y773). |
 antibody) Anti-Phospho-Integrin beta (Y795) antibody |
|
STJ90656 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Rabbit polyclonal to Phospho-Integrin beta1 (Y795). |
 antibody) Anti-Phospho-Integrin beta (Y785) antibody |
|
STJ90684 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Rabbit polyclonal to Phospho-Integrin beta3 (Y785). |
 antibody) Anti-Phospho-Integrin beta (Y1510) antibody |
|
STJ90915 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Rabbit polyclonal to Phospho-Integrin beta4 (Y1510). |
 antibody) Anti-Phospho-Integrin beta (T789) antibody |
|
STJ91039 |
St John's Laboratory |
200 µl |
EUR 197 |
|
Description: Rabbit polyclonal to Phospho-Integrin beta1 (T789). |
 anti- Integrin beta-6-Specific antibody |
|
FNab04354 |
FN Test |
100µg |
EUR 585 |
|
|
|
Description: Antibody raised against Integrin beta-6-Specific |
 anti-integrin beta 4 binding protein |
|
YF-PA24022 |
Abfrontier |
50 ul |
EUR 334 |
|
Description: Mouse polyclonal to integrin beta 4 binding protein |
 ELISA Kit) Human Integrin Beta 2 (ITGb2) ELISA Kit |
|
SEB586Hu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 4502.43 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Integrin Beta 2 (ITGb2) in Tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Integrin Beta 2 (ITGb2) ELISA Kit |
|
SEB586Hu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 458.44 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Integrin Beta 2 (ITGb2) in Tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Integrin Beta 2 (ITGb2) ELISA Kit |
|
SEB586Hu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 612.05 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Integrin Beta 2 (ITGb2) in Tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Integrin Beta 2 (ITGb2) ELISA Kit |
|
SEB586Hu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 2454.23 |
|
|
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Integrin Beta 2 (ITGb2) in Tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
Human Integrin Beta 2 (ITGb2) ELISA Kit |
|
4-SEB586Hu |
Cloud-Clone |
-
EUR 4553.00
-
EUR 2405.00
-
EUR 613.00
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Integrin Beta 2 (ITGb2) in samples from Tissue homogenates, cell lysates, cell culture supernates and other biological fluids. with no significant corss-reactivity with analogues from other species. |
 Polyclonal Antibody (Human)) Integrin Beta 2 (ITGb2) Polyclonal Antibody (Human) |
|
4-PAB586Hu01 |
Cloud-Clone |
-
EUR 239.00
-
EUR 2391.00
-
EUR 598.00
-
EUR 299.00
-
EUR 211.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Integrin Beta 2 (ITGb2) |
Integrin Beta 2 (ITGb2) Polyclonal Antibody (Human) |
|
4-PAB586Hu02 |
Cloud-Clone |
-
EUR 239.00
-
EUR 2391.00
-
EUR 598.00
-
EUR 299.00
-
EUR 211.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
|
|
Description: A Rabbit polyclonal antibody against Human Integrin Beta 2 (ITGb2) |
 Human ITGB2/ Integrin beta-2 ELISA Kit |
|
E1348Hu |
Sunlong |
1 Kit |
EUR 571 |
 CLIA Kit) Human Integrin Beta 2 (ITGb2) CLIA Kit |
|
20-abx492891 |
Abbexa |
-
EUR 7973.00
-
EUR 4246.00
-
EUR 981.00
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
|
Human Integrin Beta 2 (ITGb2) ELISA Kit |
|
20-abx151992 |
Abbexa |
-
EUR 7112.00
-
EUR 3792.00
-
EUR 879.00
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
|
Human Integrin Beta 2 (ITGb2) ELISA Kit |
|
abx251551-96tests |
Abbexa |
96 tests |
EUR 668 |
|
|
) Human Integrin Beta 2 ELISA Kit (ITGb2) |
|
RK01705 |
Abclonal |
96 Tests |
EUR 521 |
 ELISA Kit) Human ITGB2(Integrin beta-2) ELISA Kit |
|
EH2209 |
FN Test |
96T |
EUR 524.1 |
|
|
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.188 ng/ml |
) Anti-Integrin beta 2/CD18 Monoclonal Antibody (68-5A5) |
|
CTA-284-100ug |
Creative Biolabs |
100ug |
Ask for price |
|
Description: Mouse anti-Integrin beta 2/CD18 monoclonal antibody (68-5A5) for Flow, PAGE, ICC/IF. |
Anti-Integrin beta 2/CD18 Monoclonal Antibody (68-5A5) |
|
CTA-284-1mg |
Creative Biolabs |
1mg |
Ask for price |
|
Description: Mouse anti-Integrin beta 2/CD18 monoclonal antibody (68-5A5) for Flow, PAGE, ICC/IF. |
 Anti- Beta-tubulin Monoclonal Antibody |
|
M05613-2 |
BosterBio |
100ul |
EUR 397 |
|
Description: Mouse Monoclonal Beta-tubulin Antibody. Validated in IF, IHC, WB and tested in Human, Monkey, Mouse, Rat. |
 Anti-IL-1 beta Antibody |
|
A00101-2 |
BosterBio |
1mg |
EUR 1232 |
|
Description: Rabbit Polyclonal IL-1 beta Antibody. Validated in IP, IHC, WB and tested in Human. |
 Anti-GLB1/Beta-galactosidase Antibody |
|
A01829-2 |
BosterBio |
100ug/vial |
EUR 334 |
 Anti-beta glucuronidase/Gusb Antibody |
|
A02234-2 |
BosterBio |
100ug/vial |
EUR 334 |
) Nori® Human Integrin alpha 6/CD49f ELISA Kit (2 plates) |
|
GR106155-2 |
Genorise Scientific |
2 x 96-well |
EUR 832 |
 Integrin beta antibody |
|
70R-31317 |
Fitzgerald |
100 ug |
EUR 327 |
|
Description: Rabbit polyclonal Integrin beta antibody |
 Integrin alpha X beta 2, CF |
|
PR15089CF |
Neuromics |
50 ug |
EUR 636 |
 Antibody (HRP)) Integrin Beta 2 (ITGB2) Antibody (HRP) |
|
20-abx315795 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody (FITC)) Integrin Beta 2 (ITGB2) Antibody (FITC) |
|
20-abx315796 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody (Biotin)) Integrin Beta 2 (ITGB2) Antibody (Biotin) |
|
20-abx315797 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
|
 Antibody Pair) Integrin Beta 2 (ITGb2) Antibody Pair |
|
20-abx370323 |
Abbexa |
|
- 10 × 96 tests
- 5 × 96 tests
|
|
|
 Protein) Rat Integrin Beta 2 (ITGb2) Protein |
|
20-abx067291 |
Abbexa |
-
EUR 704.00
-
EUR 286.00
-
EUR 2165.00
-
EUR 829.00
-
EUR 495.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Protein) Mouse Integrin Beta 2 (ITGb2) Protein |
|
20-abx067292 |
Abbexa |
-
EUR 690.00
-
EUR 286.00
-
EUR 2124.00
-
EUR 815.00
-
EUR 495.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
|
 Antibody (FITC)) Integrin Beta-2 (ITGB2) Antibody (FITC) |
|
abx133976-100Assays |
Abbexa |
100 Assays |
EUR 439 |
|
|
Integrin Beta-2 (ITGB2) Antibody (FITC) |
|
abx133976-50Assays |
Abbexa |
50 Assays |
EUR 342 |
|
|
 Antibody (PE)) Integrin Beta-2 (CD18) Antibody (PE) |
|
abx133977-100Assays |
Abbexa |
100 Assays |
EUR 495 |
|
|
Integrin Beta-2 (CD18) Antibody (PE) |
|
abx133977-50Assays |
Abbexa |
50 Assays |
EUR 398 |
|
|
Integrin Beta-2 (CD18) Antibody (PE) |
|
abx139645-100tests |
Abbexa |
100 tests |
EUR 481 |
|
|
 Antibody (APC)) Integrin Beta-2 (CD18) Antibody (APC) |
|
abx139646-100tests |
Abbexa |
100 tests |
EUR 481 |
|
|
Integrin Beta-2 (CD18) Antibody (PE) |
|
abx139647-100tests |
Abbexa |
100 tests |
EUR 481 |
|
|
Integrin Beta-2 (CD18) Antibody (APC) |
|
abx139648-100tests |
Abbexa |
100 tests |
EUR 481 |
|
|
Integrin Beta 2 (ITGB2) Antibody (FITC) |
|
abx413586-01mg |
Abbexa |
0.1 mg |
EUR 746 |
|
|
 Antibody (RPE)) Integrin Beta 2 (ITGB2) Antibody (RPE) |
|
abx413588-100tests |
Abbexa |
100 tests |
EUR 718 |
|
|
 Antibody (FITC)) Integrin Beta-2 (CD18) Antibody (FITC) |
|
abx413683-01mg |
Abbexa |
0.1 mg |
EUR 578 |
|
|
 Antibody (RPE)) Integrin Beta-2 (CD18) Antibody (RPE) |
|
abx413684-100tests |
Abbexa |
100 tests |
EUR 676 |
|
|
Integrin Beta-2 (CD18) Antibody (RPE) |
|
abx413685-25tests |
Abbexa |
25 tests |
EUR 356 |
|
|
Integrin Beta-2 (CD18) Antibody (FITC) |
|
abx414289-01mg |
Abbexa |
0.1 mg |
EUR 509 |
|
|
Integrin Beta-2 (CD18) Antibody (FITC) |
|
abx414998-100tests |
Abbexa |
100 tests |
EUR 509 |
|
|
Integrin Beta-2 (CD18) Antibody (RPE) |
|
abx415000-100tests |
Abbexa |
100 tests |
EUR 592 |
|
|
Integrin Beta-2 (CD18) Antibody (RPE) |
|
abx415001-25tests |
Abbexa |
25 tests |
EUR 314 |
|
|
Integrin Beta-2 (CD18) Antibody (FITC) |
|
abx415526-01mg |
Abbexa |
0.1 mg |
EUR 509 |
|
|
Integrin Beta-2 (CD18) Antibody (RPE) |
|
abx415527-100tests |
Abbexa |
100 tests |
EUR 592 |
|
|
Integrin Beta-2 (ITGB2) Antibody (FITC) |
|
abx200154-100tests |
Abbexa |
100 tests |
EUR 398 |
|
|
The research will embody a baseline survey, a pre- and post-test survey and a 3-month lasting intervention on (1) hygiene and prevention and (2) coronavirus consciousness and prevention. Girls of reproductive years can be sampled from deprived areas throughout the 4 provinces of Pakistan (Baluchistan, Khyber Pakhtunkhwa, Punjab and Sindh), and the choice standards can be poor, semiliterate or illiterate, belonging to underdeveloped neighbourhoods devoid of common healthcare protection and depending on free main well being companies. A goal of 1000 ladies will comprise the pattern, with 500 ladies every assigned randomly to the intervention and management teams. Evaluation of variance and multivariate evaluation can be used for analysing the intervention’s results in contrast with the management group.
